Journal article icon

Journal article

Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts

Abstract:

Animal and experimental data suggest that anti-Müllerian hormone (AMH) serves as a marker of ovarian reserve and inhibits the growth of ovarian tumors. However, few epidemiologic studies have examined the association between AMH and ovarian cancer risk. We conducted a nested case-control study of 302 ovarian cancer cases and 336 matched controls from nine cohorts. Prediagnostic blood samples of premenopausal women were assayed for AMH using a picoAMH enzyme-linked immunosorbent assay. Odds ra...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1002/ijc.31058

Authors


More by this author
Role:
Author
ORCID:
0000-0002-9887-2389
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
Publisher:
Wiley
Journal:
International Journal of Cancer More from this journal
Volume:
142
Issue:
2
Pages:
262-270
Publication date:
2017-09-18
Acceptance date:
2017-08-16
DOI:
EISSN:
1097-0215
ISSN:
0020-7136
Pmid:
28921520
Language:
English
Keywords:
Pubs id:
pubs:730172
UUID:
uuid:fa18e1c9-8048-4c15-8f04-474fbd87196f
Local pid:
pubs:730172
Source identifiers:
730172
Deposit date:
2019-02-28

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP